U.S. flag

An official website of the United States government

NM_000152.5(GAA):c.1610del (p.Glu537fs) AND Glycogen storage disease, type II

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Jun 6, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001937792.6

Allele description [Variation Report for NM_000152.5(GAA):c.1610del (p.Glu537fs)]

NM_000152.5(GAA):c.1610del (p.Glu537fs)

Gene:
GAA:alpha glucosidase [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
17q25.3
Genomic location:
Preferred name:
NM_000152.5(GAA):c.1610del (p.Glu537fs)
HGVS:
  • NC_000017.11:g.80110999del
  • NG_009822.1:g.14444del
  • NM_000152.5:c.1610delMANE SELECT
  • NM_001079803.3:c.1610del
  • NM_001079804.3:c.1610del
  • NP_000143.2:p.Glu537fs
  • NP_001073271.1:p.Glu537fs
  • NP_001073272.1:p.Glu537fs
  • LRG_673:g.14444del
  • NC_000017.10:g.78084798del
Protein change:
E537fs
Links:
dbSNP: rs762060817
NCBI 1000 Genomes Browser:
rs762060817
Molecular consequence:
  • NM_000152.5:c.1610del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001079803.3:c.1610del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001079804.3:c.1610del - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:
Glycogen storage disease, type II (GSD2)
Synonyms:
ACID ALPHA-GLUCOSIDASE DEFICIENCY; GLYCOGENOSIS, GENERALIZED, CARDIAC FORM; GSD II; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0009290; MedGen: C0017921; Orphanet: 365; OMIM: 232300

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002184993Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Jun 6, 2023)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Update of the Pompe variant database for the prediction of clinical phenotypes: Novel disease-associated variants, common sequence variants, and results from newborn screening.

de Faria DOS, 't Groen SLMI, Hoogeveen-Westerveld M, Nino MY, van der Ploeg AT, Bergsma AJ, Pijnappel WWMP.

Hum Mutat. 2021 Feb;42(2):119-134. doi: 10.1002/humu.24148. Epub 2020 Dec 21.

PubMed [citation]
PMID:
33560568
PMCID:
PMC7898817

Update of the Pompe disease mutation database with 107 sequence variants and a format for severity rating.

Kroos M, Pomponio RJ, van Vliet L, Palmer RE, Phipps M, Van der Helm R, Halley D, Reuser A; GAA Database Consortium..

Hum Mutat. 2008 Jun;29(6):E13-26. doi: 10.1002/humu.20745.

PubMed [citation]
PMID:
18425781
See all PubMed Citations (4)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV002184993.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 1407438). This premature translational stop signal has been observed in individual(s) with Pompe disease (PMID: 33560568; Invitae). This variant is present in population databases (rs762060817, gnomAD 0.002%). This sequence change creates a premature translational stop signal (p.Glu537Glyfs*41) in the GAA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GAA are known to be pathogenic (PMID: 18425781, 22252923).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024